• Complete Genomics Appoints Former U.S. Ambassador Edward T. McMullen Jr. to Board of Directors

  Jun 9, 2026Jun 8, 2026

• New study demonstrates up to 73% reduction in genome analysis errors using AI-trained models versus standard approaches 

  Apr 29, 2026Apr 29, 2026

• Newsletter – Q1 2026

  Mar 18, 2026Apr 13, 2026

• Complete Genomics Highlights DNBSEQ-T7+ at AGBT 2026, Expanding High-Throughput Sequencing Capability 

  Feb 24, 2026Mar 9, 2026

• Complete Genomics Enters Definitive Agreement to Be Acquired by Swiss Rockets AG  

  Feb 23, 2026Feb 22, 2026

• Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform for Comprehensive Genomic Profiling at AMP 2025

  Nov 11, 2025Feb 10, 2026

• Complete Genomics Highlights Clinical Research Sequencing Solutions and Partnerships at AMP 2025

  Nov 11, 2025Feb 10, 2026

• Complete Genomics Highlights New Products, Partnerships, First DNBSEQ User Group Meeting at ASHG 2025

  Oct 14, 2025Feb 10, 2026

• Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG

  Oct 13, 2025Feb 10, 2026

• Complete Genomics, Velsera partner to integrate sequencing and analysis platforms

  Apr 28, 2025Feb 10, 2026

• Complete Genomics Names Four Winners of Spatial Xcellerator Grant Program

  Apr 15, 2025Feb 10, 2026

• Complete Genomics Announces Partnership with BioTuring and the Go Optical STOmics Microscope

  Mar 25, 2025Feb 10, 2026